| Predicate |
Object |
| contentType |
Review|Journal Article |
| endingPage |
854 |
| issn |
1874-4672 |
| issueIdentifier |
8 |
| pageRange |
832-854 |
| publicationName |
Current Molecular Pharmacology |
| startingPage |
832 |
| bibliographicCitation |
Gupta J, Gupta R. PCSK9 Biomarker and Key Modulator for Cardiovascular Disorders: Heralding a New Therapeutic Era and Their Future Perspectives. Curr Mol Pharmacol. 2023;16(8):832–54. doi: 10.2174/1874467216666221202144813. PMID: 36476440. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8453-0142
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0503-8580 |
| date |
202312 |
| identifier |
https://doi.org/10.2174/1874467216666221202144813
https://pubmed.ncbi.nlm.nih.gov/36476440 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1874-4672
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34539 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
PCSK9 Biomarker and Key Modulator for Cardiovascular Disorders: Heralding a New Therapeutic Era and Their Future Perspectives |
| discusses |
http://id.nlm.nih.gov/mesh/M000614708
http://id.nlm.nih.gov/mesh/M0449043
http://id.nlm.nih.gov/mesh/M0012591
http://id.nlm.nih.gov/mesh/M0447016
http://id.nlm.nih.gov/mesh/M0023752 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D002318Q000188
http://id.nlm.nih.gov/mesh/D000071449Q000378 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D043484
http://id.nlm.nih.gov/mesh/D015415
http://id.nlm.nih.gov/mesh/D008078
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.61
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_47d076e180ade31f7985c0914d943f8b
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0b5b5e68b6d711f5dfe1be91cd96a2ef |